Antineoplastic AgentsDrug Screening Assays, AntitumorCell Line, TumorRadiation DosageRadiation, IonizingNeoplasmsRadiation InjuriesApoptosisMolecular Sequence DataDrug Resistance, NeoplasmDose-Response Relationship, RadiationAntineoplastic Agents, PhytogenicDoxorubicinRadiation ToleranceCell SurvivalRadiationAntibiotics, AntineoplasticAmino Acid SequenceTumor Cells, CulturedXenograft Model Antitumor AssaysRadiation ProtectionMice, NudeRadiation MonitoringCisplatinInhibitory Concentration 50Drug Delivery SystemsCell ProliferationBase SequenceMolecular StructureKineticsDose-Response Relationship, DrugDrug Resistance, MultipleCamptothecinDrug CarriersDNA DamageDrug DesignGrateful MedDrug SynergismCell CycleSaccharomyces cerevisiaeEtoposideDrug ResistanceMediator ComplexP-GlycoproteinEllipticinesPaclitaxelEnzyme InhibitorsTopoisomerase I InhibitorsRadiation OncologyBreast NeoplasmsRadiation-Sensitizing AgentsProdrugsDNA Topoisomerases, Type IIGamma RaysPlant ExtractsGene Expression Regulation, NeoplasticClinical Trials, Phase I as TopicStructure-Activity RelationshipDrug Evaluation, PreclinicalSignal TransductionTime FactorsColonic NeoplasmsCosmic RadiationCell DivisionCaspasesRadiation Injuries, ExperimentalTopoisomerase InhibitorsPlatinumTumor Suppressor Protein p53Neoplasm TransplantationDNADaunorubicinMutationAntimetabolites, AntineoplasticCell LineTubulin ModulatorsDrugs, InvestigationalBlotting, WesternRadiation PneumonitisHT29 CellsUltraviolet RaysHCT116 CellsFluorouracilNeoplasms, ExperimentalCaspase 3Mediator Complex Subunit 1Combined Modality TherapyNanoparticlesProto-Oncogene Proteins c-bcl-2Cell DeathAnticarcinogenic AgentsNeoplasms, Radiation-InducedDNA RepairMolecular Targeted TherapyAntineoplastic Agents, AlkylatingRadiotherapyLeukemia P388NanomedicineModels, BiologicalTransplantation, Heterologous